A detailed history of Geneos Wealth Management Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 3,747 shares of BDX stock, worth $851,205. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,747
Previous 2,930 27.88%
Holding current value
$851,205
Previous $684,000 32.02%
% of portfolio
0.03%
Previous 0.03%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$221.47 - $242.41 $180,940 - $198,048
817 Added 27.88%
3,747 $903,000
Q2 2024

Jul 23, 2024

BUY
$225.07 - $246.17 $86,201 - $94,283
383 Added 15.04%
2,930 $684,000
Q1 2024

May 03, 2024

BUY
$233.45 - $247.73 $67,000 - $71,098
287 Added 12.7%
2,547 $630,000
Q4 2023

Jan 26, 2024

SELL
$232.24 - $267.23 $71,762 - $82,574
-309 Reduced 12.03%
2,260 $551,000
Q3 2023

Oct 11, 2023

BUY
$254.9 - $283.59 $32,117 - $35,732
126 Added 5.16%
2,569 $664,000
Q2 2023

Aug 08, 2023

BUY
$238.39 - $265.32 $81,529 - $90,739
342 Added 16.28%
2,443 $644,000
Q1 2023

Apr 25, 2023

SELL
$229.71 - $259.35 $64,548 - $72,877
-281 Reduced 11.8%
2,101 $520,000
Q4 2022

Jan 30, 2023

SELL
$218.29 - $256.91 $19,864 - $23,378
-91 Reduced 3.68%
2,382 $605,000
Q3 2022

Nov 14, 2022

SELL
$51.03 - $264.23 $33,883 - $175,448
-664 Reduced 21.17%
2,473 $551,000
Q2 2022

Jul 22, 2022

SELL
$234.74 - $275.42 $5,399 - $6,334
-23 Reduced 0.73%
3,137 $773,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $38,495 - $42,735
158 Added 5.26%
3,160 $840,000
Q4 2021

Feb 09, 2022

BUY
$230.08 - $250.94 $14,264 - $15,558
62 Added 2.11%
3,002 $755,000
Q3 2021

Nov 09, 2021

BUY
$232.72 - $256.47 $11,170 - $12,310
48 Added 1.66%
2,940 $719,000
Q2 2021

Jul 08, 2021

SELL
$232.65 - $254.58 $379,684 - $415,474
-1,632 Reduced 36.07%
2,892 $718,000
Q1 2021

Jun 17, 2021

SELL
$232.09 - $256.88 $154,339 - $170,825
-665 Reduced 12.82%
4,524 $1.13 Million
Q4 2020

May 19, 2021

BUY
$221.92 - $245.94 $506,643 - $561,481
2,283 Added 78.56%
5,189 $1.27 Million
Q3 2020

Sep 07, 2021

SELL
$215.77 - $276.76 $10,141 - $13,007
-47 Reduced 1.59%
2,906 $651,000
Q2 2020

Sep 07, 2021

BUY
$219.9 - $263.41 $23,529 - $28,184
107 Added 3.76%
2,953 $689,000
Q1 2020

Sep 07, 2021

BUY
$195.69 - $279.01 $5,283 - $7,533
27 Added 0.96%
2,846 $616,000
Q4 2019

Sep 07, 2021

BUY
$236.45 - $266.82 $472 - $533
2 Added 0.07%
2,819 $769,000
Q3 2019

Sep 07, 2021

SELL
$230.58 - $256.08 $127,049 - $141,100
-551 Reduced 16.36%
2,817 $698,000
Q2 2019

Sep 07, 2021

BUY
$217.4 - $246.08 $1,739 - $1,968
8 Added 0.24%
3,368 $848,000
Q1 2019

Sep 07, 2021

SELL
$206.05 - $248.17 $41,416 - $49,882
-201 Reduced 5.64%
3,360 $839,000
Q4 2018

Sep 07, 2021

SELL
$204.73 - $257.93 $41,969 - $52,875
-205 Reduced 5.44%
3,561 $790,000
Q3 2018

Sep 07, 2021

BUY
$233.07 - $256.0 $87,634 - $96,256
376 Added 11.09%
3,766 $983,000
Q2 2018

Sep 07, 2021

SELL
$208.1 - $233.85 $9,364 - $10,523
-45 Reduced 1.31%
3,390 $812,000
Q1 2018

Sep 07, 2021

BUY
$205.46 - $240.27 $198,268 - $231,860
965 Added 39.07%
3,435 $744,000
Q4 2017

Sep 07, 2021

BUY
$189.0 - $222.64 $8,883 - $10,464
47 Added 1.94%
2,470 $528,000
Q3 2017

Sep 07, 2021

BUY
$186.89 - $198.9 $5,232 - $5,569
28 Added 1.17%
2,423 $474,000
Q2 2017

Sep 07, 2021

BUY
N/A
39 Added 1.66%
2,395 $467,000
Q1 2017

Sep 07, 2021

BUY
N/A
393 Added 20.02%
2,356 $432,000
Q4 2016

Sep 07, 2021

SELL
N/A
-381 Reduced 16.25%
1,963 $325,000
Q3 2016

Sep 07, 2021

BUY
N/A
3 Added 0.13%
2,344 $421,000
Q2 2016

Sep 07, 2021

SELL
N/A
-46 Reduced 1.93%
2,341 $397,000
Q1 2016

Sep 07, 2021

BUY
N/A
2,387
2,387 $366,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Geneos Wealth Management Inc. Portfolio

Follow Geneos Wealth Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geneos Wealth Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Geneos Wealth Management Inc. with notifications on news.